The well-documented association between metabolic conditions, such as type 2 diabetes mellitus (T2DM) and obesity, and the risk of dementia has created opportunities for repurposing metabolic drugs for neurological disorders (Long and Holtzman, 2019)
Understanding the Enemy: The Immunology of RA To conquer RA, we must first map its treacherous terrain
Peptide Sequence (IUPAC Condensed): H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2 Molecular Formula: C152H252N44O42 Molecular Weight: 3367.9 g/mol Synonyms: DAC:GRF View the CJC-1295 DAC Certificate Of Analysis (COA) View the CJC-1295 DAC High Performance Liquid Chromatography (HPLC) CJC-1295 with Drug Affinity Complex is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH), distinguished by its specialized amino acid sequence and DAC modification
[PMID: 3081044] PubMed record related to this compound for laboratory literature review
As patients reduce food intake and sometimes forget to maintain fluid consumption, their overall hydration status declines
Patients should confirm how their patient-specific medical needs are documented